BioCentury | Dec 9, 2020
Deals
Reneo to start pivotal trial in mitochondrial diseases, build orphan pipeline with Novo, Abingworth-led $95M series B
...Novus Therapeutics Inc. (NASDAQ:NVUS) and Otic Pharma Ltd. as well as the CBO role at Avanir Pharmaceuticals Inc....